Gut bacteria, collectively referred to as the gut microbiota, form a complex and diverse community of microorganisms inhabiting the gastrointestinal tract. Comprising bacteria, viruses, fungi, and other microbes, this ecosystem plays a fundamental role in maintaining overall health. The gut microbiota aids in digestion, nutrient absorption, and the synthesis of certain vitamins. Beyond digestive functions, gut bacteria actively contribute to the immune system's development and regulation, influencing immune responses throughout the body. They produce metabolites, such as short-chain fatty acids, that impact host physiology and play a role in metabolic processes. The composition of gut bacteria is influenced by various factors, including diet, lifestyle, and genetics. A balanced and diverse microbiota is associated with better health outcomes, while disruptions (dysbiosis) may contribute to various disorders, including gastrointestinal issues, metabolic conditions, and immune-related diseases. Research continues to uncover the intricate interactions between gut bacteria and various aspects of health, leading to insights into potential therapeutic interventions. Probiotics, prebiotics, and dietary strategies are explored to modulate and support the gut microbiota, emphasizing the significance of this microbial community in maintaining a harmonious balance within the body.
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe